1. Home
  2. WT vs ADPT Comparison

WT vs ADPT Comparison

Compare WT & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WT
  • ADPT
  • Stock Information
  • Founded
  • WT 1985
  • ADPT 2009
  • Country
  • WT United States
  • ADPT United States
  • Employees
  • WT N/A
  • ADPT N/A
  • Industry
  • WT Investment Bankers/Brokers/Service
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WT Finance
  • ADPT Health Care
  • Exchange
  • WT Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • WT 1.4B
  • ADPT 1.2B
  • IPO Year
  • WT N/A
  • ADPT 2019
  • Fundamental
  • Price
  • WT $9.28
  • ADPT $8.27
  • Analyst Decision
  • WT Buy
  • ADPT Buy
  • Analyst Count
  • WT 8
  • ADPT 5
  • Target Price
  • WT $12.28
  • ADPT $9.10
  • AVG Volume (30 Days)
  • WT 1.5M
  • ADPT 1.5M
  • Earning Date
  • WT 01-31-2025
  • ADPT 02-11-2025
  • Dividend Yield
  • WT 1.29%
  • ADPT N/A
  • EPS Growth
  • WT N/A
  • ADPT N/A
  • EPS
  • WT 0.33
  • ADPT N/A
  • Revenue
  • WT $427,737,000.00
  • ADPT $178,957,000.00
  • Revenue This Year
  • WT $8.43
  • ADPT $20.67
  • Revenue Next Year
  • WT $6.94
  • ADPT $21.79
  • P/E Ratio
  • WT $28.12
  • ADPT N/A
  • Revenue Growth
  • WT 22.55
  • ADPT 5.10
  • 52 Week Low
  • WT $7.74
  • ADPT $2.28
  • 52 Week High
  • WT $12.45
  • ADPT $8.95
  • Technical
  • Relative Strength Index (RSI)
  • WT 30.92
  • ADPT 58.94
  • Support Level
  • WT $9.21
  • ADPT $8.09
  • Resistance Level
  • WT $9.87
  • ADPT $8.69
  • Average True Range (ATR)
  • WT 0.26
  • ADPT 0.64
  • MACD
  • WT -0.02
  • ADPT -0.00
  • Stochastic Oscillator
  • WT 7.53
  • ADPT 65.66

About WT WisdomTree Inc.

WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models, and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: